House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Faculty of 1000 evaluation for Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718003052.793477487 ◽

2013 ◽

Author(s):

Phillip Lieberman

Keyword(s):

Allergic Rhinitis ◽

House Dust ◽

House Dust Mite ◽

Controlled Trial ◽

Onset Of Action ◽

Double Blind ◽

Double Blind Placebo ◽

Fast Onset ◽

Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D. pt.) in children

Pediatric Allergy and Immunology ◽

10.1111/j.1399-3038.1997.tb00138.x ◽

1997 ◽

Vol 8 (1) ◽

pp. 21-27 ◽

Cited By ~ 127

Author(s):

Th. Hirsch ◽

M. Sähn ◽

W. Leupold

Keyword(s):

House Dust ◽

House Dust Mite ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Mite Extract ◽

Dust Mite ◽

House Dust Mite Extract

Fast onset of action of sublingual immunotherapy in house dust mite-induced allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled trial

The Laryngoscope ◽

10.1002/lary.23935 ◽

2013 ◽

Vol 123 (6) ◽

pp. 1334-1340 ◽

Cited By ~ 40

Author(s):

De-Hui Wang ◽

Lei Chen ◽

Lei Cheng ◽

Ke-Nan Li ◽

Hu Yuan ◽

...

Keyword(s):

Allergic Rhinitis ◽

House Dust ◽

House Dust Mite ◽

Controlled Trial ◽

Onset Of Action ◽

Double Blind ◽

Double Blind Placebo ◽

Fast Onset ◽

A randomized, double-blind, placebo-controlled study of Ten-Cha (Rubus suavissimus) on house dust mite allergic rhinitis

Auris Nasus Larynx ◽

10.1016/j.anl.2010.11.017 ◽

2011 ◽

Vol 38 (5) ◽

pp. 600-607 ◽

Cited By ~ 8

Author(s):

Syuji Yonekura ◽

Yoshitaka Okamoto ◽

Kazuki Yamasaki ◽

Shigetoshi Horiguchi ◽

Toyoyuki Hanazawa ◽

...

Keyword(s):

Allergic Rhinitis ◽

House Dust ◽

House Dust Mite ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial

Clinical and Translational Allergy ◽

10.1186/s13601-017-0180-9 ◽

2017 ◽

Vol 7 (1) ◽

Cited By ~ 11

Author(s):

Andrzej Bożek ◽

Krzysztof Kołodziejczyk ◽

Renata Kozłowska ◽

Giorgio Walter Canonica

Keyword(s):

Allergic Rhinitis ◽

House Dust ◽

House Dust Mite ◽

Controlled Trial ◽

Subcutaneous Immunotherapy ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2020.07.036 ◽

2020 ◽

Cited By ~ 1

Author(s):

Pascal Demoly ◽

Jonathan Corren ◽

Peter Creticos ◽

Frédéric De Blay ◽

Philippe Gevaert ◽

...

Keyword(s):

Clinical Trial ◽

Allergic Rhinitis ◽

House Dust ◽

House Dust Mite ◽

Phase Iii ◽

Double Blind ◽

Sublingual Tablet ◽

Double Blind Placebo ◽

Phase Iii Clinical Trial ◽

Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: A randomized, double-blind, placebo-controlled trial

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2014.03.019 ◽

2014 ◽

Vol 134 (3) ◽

pp. 568-575.e7 ◽

Cited By ~ 151

Author(s):

Holger Mosbech ◽

Regina Deckelmann ◽

Fréderic de Blay ◽

Elide Anna Pastorello ◽

Ewa Trebas-Pietras ◽

...

Keyword(s):

Asthma Control ◽

House Dust ◽

House Dust Mite ◽

Controlled Trial ◽

Inhaled Corticosteroid ◽

Double Blind ◽

Double Blind Placebo ◽

Safety profile of the SQ house dust mite sublingual immunotherapy-tablet in Japanese adult patients with house dust mite-induced allergic asthma: a randomized, double-blind, placebo-controlled phase I study

Journal of Asthma ◽

10.1080/02770903.2018.1541353 ◽

2018 ◽

Vol 56 (12) ◽

pp. 1347-1355 ◽

Cited By ~ 3

Author(s):

Kazuhiro Okamiya ◽

Hisakuni Sekino ◽

Ryuji Azuma ◽

Minoru Kudo ◽

Miyuki Sakaguchi ◽

...

Keyword(s):

Phase I ◽

House Dust ◽

House Dust Mite ◽

Safety Profile ◽

Phase I Study ◽

Japanese Adult ◽

Double Blind ◽

Double Blind Placebo ◽

House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study

Allergy ◽

10.1034/j.1398-9995.2000.00413.x ◽

2000 ◽

Vol 55 (4) ◽

pp. 369-375 ◽

Cited By ~ 113

Author(s):

S. Guez ◽

C. Vatrinet ◽

R. Fadel ◽

C. André

Keyword(s):

House Dust ◽

House Dust Mite ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Dust Mite ◽

Perennial Rhinitis

Effective treatment of house dust mite–induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2015.06.036 ◽

2016 ◽

Vol 137 (2) ◽

pp. 444-451.e8 ◽

Cited By ~ 122

Author(s):

Pascal Demoly ◽

Waltraud Emminger ◽

Dorte Rehm ◽

Vibeke Backer ◽

Lene Tommerup ◽

...

Keyword(s):

Allergic Rhinitis ◽

Effective Treatment ◽

House Dust ◽

House Dust Mite ◽

Phase Iii ◽

Double Blind ◽

Phase Iii Trial ◽

Double Blind Placebo ◽